Dr. Jason Robert Guertin is a researcher at the Centre de recherche du CHU de Québec – Laval University and an assistant professor in the Department of Preventive and Social Medicine of Université Laval’s Faculty of Medicine.

Financial evaluation is a pivotal component of health technology assessment. It aims to support decision-makers to establish if adopting a novel health technology represents the most efficient use of available resources. Considering that healthcare demands are continuously on the rise, and budgets are overstretched, many health technology assessment units in Canada and abroad are examining the option of reassessing the value of previously adopted technologies using observational economic revaluations. Dr. Guertin’s research program focuses on the various components of economic evaluations and revaluations conducted within an observational setting. More recently, his work has focused on: 1) the development of novel methods aimed at addressing limits associated with observational economic evaluations; 2) evaluating the impact of chronic diseases on patients’ health-related quality of life in Quebec and Canada; and 3) the economic evaluation of health technologies in the field of personalized medicine.

Hôpital Saint-Sacrement
1050 Chemin Sainte-Foy
J1-09B
Québec, QC
Canada G1S 4L8
+1 418-525-4444, extension 82516
jason-robert.guertin@crch... jason.guertin@fmed.ulaval...

Latest news

62 entries « ‹ 6 of 7 › »

Guertin J, LeLorier J, Durand M, Gow R, Holbrook A, Levine M

Impact of a restrictive drug access program on the risk of cardiovascular encounters in children exposed to ADHD medications

Journal Article

J Popul Ther Clin Pharmacol, 21 (3), 2014.

Abstract | Links:

Boothroyd LJ, Lambert LJ, Ducharme A, Guertin JR, Sas G, Charbonneau E, Carrier M, Cecere R, Morin JE, Bogaty P

Challenge of informing patient decision making: what can we tell patients considering long-term mechanical circulatory support about outcomes, daily life, and end-of-life issues?

Journal Article

Circ Cardiovasc Qual Outcomes, 7 (1), 2014.

| Links:

Poulin F, Khairy P, Roy D, Levesque S, Talajic M, Guertin JR, Lelorier J,

Atrial fibrillation and congestive heart failure: a cost analysis of rhythm-control vs. rate-control strategies

Journal Article

Can J Cardiol, 29 (10), 2013.

Abstract | Links:

Boothroyd LJ, Lambert LJ, Sas G, Guertin JR, Ducharme A, Charbonneau E, Carrier M, Cecere R, Morin JE, Bogaty P

Should eligibility for heart transplantation be a requirement for left ventricular assist device use? Recommendations based on a systematic review

Journal Article

Can J Cardiol, 29 (12), 2013.

Abstract | Links:

Boothroyd LJ, Spaziano M, Guertin JR, Lambert LJ, Rodes-Cabau J, Noiseux N, Nguyen M, Dumont E, Carrier M, de Varennes B, Ibrahim R, Martucci G, Xiao Y, Morin JE, Bogaty P

Transcatheter aortic valve implantation: recommendations for practice based on a multidisciplinary review including cost-effectiveness and ethical and organizational issues

Journal Article

Can J Cardiol, 29 (6), 2013.

Abstract | Links:

Sas G, Boothroyd LJ, Guertin JR, Lambert LJ, Morin JE, Chakor H, Bogaty P

Évaluation des données probantes sur les dispositifs d'assistance ventriculaire gauche HeartMate II et HeartWare pour le traitement de l'insuffisance cardiaque chronique terminale : avis

Book

Institut national d’excellence en santé et en services sociaux (INESSS), Québec, QC, 2012, ISBN: 9782550660378.

Spaziano M, Boothroyd LJ, Guertin JR, Chakor H, Xiao Y, Lambert LJ, Bogaty P

Implantation valvulaire aortique par cathéter. Évaluation des données probantes et synthèse des considérations organisationnelles : avis

Book

Institut national d’excellence en santé et en services sociaux (INESSS), Québec, QC, 2012, ISBN: 9782550648659.

Kamdeu Fansi AA, Guertin JR, LeLorier J

Savings from the use of a probiotic formula in the prophylaxis of antibiotic-associated diarrhea

Journal Article

J Med Econ, 15 (1), 2012.

Abstract | Links:

Guertin JR, Liu A, Abrahamowicz M, Cohen DJ, Ismail S, LeLorier J, Brophy JM, Rinfret S

Willingness to pay to eliminate the risk of restenosis following percutaneous coronary intervention: a contingent valuation

Journal Article

Circ Cardiovasc Qual Outcomes, 4 (1), 2011.

Abstract | Links:

Guertin JR, Jackevicius CA, Cox JL, Humphries K, Pilote L, So DY, Tu JV, Wijeysundera H, Rinfret S,

The potential economic impact of restricted access to angiotensin-receptor blockers

Journal Article

CMAJ, 183 (3), 2011.

Abstract | Links:

62 entries « ‹ 6 of 7 › »
Signaler des ajouts ou des modifications

Active projects

  • Audit & Feedback Module Targeting Low-Value Clinical Practices in Injury Care: an Economic Evaluation, from 2020-04-01 to 2023-03-31
  • Clinical validity and clinical utility of a screening test for Paget's disease of bone, from 2019-03-01 to 2023-03-31
  • Coûts des maladies cardiovasculaires et des problèmes de santé mentale attribuables aux contraintes psychosociales au travail : Une étude longitudinale de 22 ans auprès de 9 000 cols blancs., from 2016-07-01 to 2024-03-31
  • Étude de l'éco-efficience du port de l'équipement de protection individuelle contre la COVID-19 dans les urgences pour un contexte post-pandémique, from 2021-10-01 to 2024-03-31
  • Étude préclinique et pharmacoépidémiologique de l’impact du dutastéride dans l’étiopathogenèse et la progression de la maladie de Parkinson, from 2021-04-01 to 2022-08-31
  • Fardeau économique des grands brûlés pour un centre hospitalier du Canada, from 2021-08-20 to 2023-09-01
  • How to better manage infectious diseases in ER by triage with molecular mini-panels for the rapid detection of highly transmissible pathogens, from 2018-10-01 to 2022-09-30
  • Infrastructure de l'évaluation économique en médecine régénératrice, from 2020-04-01 to 2023-03-31
  • Optimisation des approches méthodologiques utilisées dans le cadre d’évaluations économiques basées sur des données observationnelles, from 2019-07-01 to 2023-06-30
  • Optimisation des approches méthodologiques utilisées dans le cadre d’évaluations économiques basées sur des données observationnelles, from 2019-07-01 to 2023-06-30
  • PEGASUS-2 - PErsonalized Genomics for prenatal Abnormalities Screening USing maternal blood : Towards First Tier Screening and Beyond, from 2018-04-01 to 2024-03-31
  • Real-World Evaluation of the Efficacy, Safety and Cost-Effectiveness of Statins for Primary Prevention of Cardiovascular Disease Among the Elderly – A Causal Perspective to Treatment Trajectory Analysis, from 2019-10-01 to 2023-03-31
  • The right care, for the right patient, at the right time, by the right provider: A value-based comparison of the management of ambulatory respiratory diseases in walk-in clinics, primary care physician practices and emergency departments, from 2020-04-01 to 2024-03-31
  • The right care, for the right patient, at the right time, by the right provider: A value-based comparison of the management of ambulatory respiratory diseases in walk-in clinics, primary care physician practices and emergency departments, from 2021-10-01 to 2025-03-31

Recently finished projects

  • Canadian Program for Monitoring Overuse in Injury Care, from 2016-07-01 to 2021-06-30
  • Pilot study of a community pharmacy-based program to enhance adherence to adjuvant endocrine therapy among breast, from 2019-10-01 to 2022-02-28
  • Programme de soutien aux nouveaux chercheurs, from 2019-07-01 to 2022-06-30
  • Quand innovations technologique et organisationnelle vont de pair: Un modèle collaboratif pour rendre l'oncogénétique plus agile, accessible et efficiente, from 2020-04-01 to 2022-03-31
  • Real-World Cost-Effectiveness of Direct Oral Anticoagulants in Atrial Fibrillation: A Canadian Health Technology Reassessment Study, from 2018-04-01 to 2020-09-30
  • The right care, for the right patient, at the right time, by the right provider: A value-based comparison of the management of ambulatory respiratory diseases in walk-in clinics, primary care physician practices and emergency departments, from 2021-03-01 to 2022-02-28
Data provided by the Université Laval research projects registery